CHU La Timone

Running trials

• Recruiting

  Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease

  NCT07274254· Phase 3· Source

• Not yet recruiting

  AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

  NCT07604727· Source

• Recruiting

  A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  NCT07169734· Phase 1/2· Source

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Source

• Recruiting

  Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

  NCT06420505· Source

• Recruiting

  MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

  NCT05691608· Source

• Recruiting

  A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

  NCT04299646· Phase 2· Source

• Active, not recruiting

  Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)

  NCT03333356· Source

• Active, not recruiting

  Feasibility of Molecular Biology in Pancreatic Cyst Tumors

  NCT03305146· Source

• Active, not recruiting

  Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

  NCT02089100· Phase 3· Source

• Recruiting

  COsegregation of VARiants in Panel of Genes

  NCT01689584· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Acute myeloid leukemia1 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Heart failure1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Sickle cell disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

  NCT05665348· Phase 2/3· Source

• Completed

  One Day Implantation Program for Heart Failure Patients Implanted With CRT-P

  NCT05142293· Source

• Completed

  [18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor

  NCT04265209· Phase 3· Source

• Completed

  Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

  NCT04753749· Source

• Completed

  Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma

  NCT04280848· Phase 2· Source

• Completed

  HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

  NCT03240731· Phase 2· Source

• Completed

  PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

  NCT03006432· Phase 3· Source